Search Results 1651-1660 of 18018 for Lupus
This phase Ib/II clinical trial studies the side effects and best dose of venetoclax and how well it works when given together with vincristine liposomal in ...
This tool could alert a patient's primary care team of a probable IPF diagnosis based on comorbidities and risk scores. The tool should prompt earlier referral ...
Experts in biomedical engineering, neurosurgery, neurology, orthopedics and more guide research in Mayo Clinic's Department of Neurologic Surgery.
How do you know when emergency care is needed? How long is isolation necessary? What can you do to prevent the spread of germs? How can you support a sick loved ...
Martin-Castillo B, Verdura S, Llop-Hernandez A, Lupu R, Cuyas E, Menendez JA. Metabolic hallmarks of trastuzumab resistance. Expert Opin Ther Targets.
Mayo Clinic researcher Louis J. Faust, Ph.D., leverages wearable health sensors to enhance healthcare delivery models and improve patient outcomes.
Progress in the diagnosis and treatment of this kidney cancer have greatly improved the outlook for children with the condition.
The purpose of this study is to see if the combination of rituximab and ibrutinib can help people with marginal zone lymphoma who have not received treatment in ...
After undergoing robotic surgery, radiation therapy and chemotherapy as part of a clinical trial to treat cancer, Bruce Trulson has gained a new understanding ...
Mayo Clinic's Division of Experimental Pathology and Laboratory Medicine uses molecular and cellular biology and epidemiological tools to study the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.